Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2008
09/18/2008CA2680222A1 Methods of treating ophthalmic diseases
09/18/2008CA2679696A1 He4 monoclonal antibodies and methods for their use
09/18/2008CA2678732A1 Monoclonal antibodies for treatment of cancer
09/18/2008CA2662246A1 Immunoreactive glycoprotein gp19 of ehrlichia canis
09/18/2008CA2658612A1 Antibodies directed to .alpha.v.beta.6 and uses thereof
09/18/2008CA2657898A1 Targeted binding agents directed to pdgfr-alpha and uses thereof
09/17/2008EP1970707A1 Method for detection of virulent strain of influenza type-a virus
09/17/2008EP1970449A1 Attenuated salmonella SPI2 mutants as antigen carriers
09/17/2008EP1970448A1 Human artificial chromosome containting human antibody lambda light chain and non-human animal containting the human artificial chromosome capable of genetic transmission
09/17/2008EP1970444A1 Method for production of antigen-specific hybridoma using artificial lymph node with good efficiency
09/17/2008EP1970386A2 Hybrid immunoglobulins
09/17/2008EP1970385A2 Tetravalent anti-CD20 and/or anti-CD23 antibodies
09/17/2008EP1970384A1 Monoclonal antibodies for treatment of cancer
09/17/2008EP1970383A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
09/17/2008EP1970073A1 Enterococcus antigens and vaccines
09/17/2008EP1969368A2 Potentiation of apoptosis by monoclonal antibodies
09/17/2008EP1969366A2 In vitro germinal centers
09/17/2008EP1969165A1 Methods for generating and screening fusion protein libraries and uses thereof
09/17/2008EP1969011A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait)
09/17/2008EP1969010A1 Anti-inflammatory dab
09/17/2008EP1969009A1 Chimeric antibodies with part new world primate binding regions
09/17/2008EP1969008A2 Antibodies against interleukin-22 binding protein and its uses for the treatment of metabolic disorders
09/17/2008EP1969007A2 Compositions and methods for producing a composition
09/17/2008EP1969003A1 Novel neurotrophic factor protein and uses thereof
09/17/2008EP1969002A1 Mcm6 and mcm7 monoclonal antibodies and methods for their use in the detection of cervical disease
09/17/2008EP1968634A2 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs
09/17/2008EP1713821A4 Primary central nervous system tumor specific behab isoforms
09/17/2008EP1563071B1 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
09/17/2008EP1509543B1 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
09/17/2008EP1412747B1 Method and antibody for detecting alcohol consumption
09/17/2008EP1409692B1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
09/17/2008EP1380646B1 Acetyllysine-recognizing monoclonal antibody and process for producing the same
09/17/2008EP1379557B1 Use of cd25 binding molecules in steroid-resistant patients
09/17/2008EP1305334B1 Urocortin proteins and uses thereof
09/17/2008EP1253941B1 Pre-transplant accommodated organs resistant to anti-donor immunity
09/17/2008EP1245676B1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
09/17/2008EP1141331B1 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
09/17/2008EP1076697B1 Semaphorin polypeptides
09/17/2008EP1017714B1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS)
09/17/2008EP0994951B1 Polynucleotides and their use for detecting resistance to streptogramin a
09/17/2008CN101268368A Methods for diagnosis and prognosis of epithelial cancers
09/17/2008CN101268101A Anti-CTLA-4 antibody and CpG-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
09/17/2008CN101267829A Thrombospondin-1 derived peptides and treatment methods
09/17/2008CN101265503A Label for distinguishing mesenchymal stem cells and method for distinguishing mesenchymal stem cells using the same
09/17/2008CN101265475A Method for preparing swine N-acetglutamic acid synthetase polyclonal antibody and application thereof
09/17/2008CN101265289A Method for preparing porcine epidemic diarrhea resisting immune globulin
09/17/2008CN101264325A RS7 antibodies
09/17/2008CN101264324A Blocking immune response to a foreign antigen using an antagonist which binds to CD20.
09/17/2008CN100419079C Compositions and methods for therapy and diagnosis of prostate cancer
09/17/2008CN100419075C Hybridoma cell strain capable of excreting monoclonal antibody of human carboxylesterase 2 and monoclonal antibody of human carboxylesterase 2
09/17/2008CN100418984C N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
09/17/2008CN100418982C Lomefloxacin conjugate and its preparing method and use
09/17/2008CN100418981C Gene differentially expressed in breast and bladder cancer and encoded polypeptides
09/16/2008US7426014 Dynamic fluid control system for immersion lithography
09/16/2008US7425623 Binding to surface of tumor cell; bacteriophage separation; in situ diagnosis
09/16/2008US7425622 Antibodies against C3a receptor
09/16/2008US7425621 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cell proliferation disorders
09/16/2008US7425620 FcγRIIB-specific antibodies and methods of use thereof
09/16/2008US7425619 FcγRIIB specific antibodies and methods of use thereof
09/16/2008US7425618 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
09/16/2008US7425617 Antibodies to the cell cycle regulatory protein p16
09/16/2008US7425616 Use of C-reactive protein to treat immune complex-mediated renal disease
09/16/2008US7425613 Glucose transport proteins for use in identifying modulators which prevent glucose uptake; diabetes diagnostic and therapeutic
09/16/2008US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders
09/16/2008US7425609 PRO4330 polypeptides
09/16/2008US7425605 PRO1486 polypeptides
09/16/2008US7425535 Therapeutic pore-forming peptides
09/16/2008US7425531 Administering bone polypeptide-1 expressed by a nucleic acid for treating a bone disorder or osteoporosis of a patient
09/16/2008US7425447 Host cells expressing 7C10 and 16C10 CD80-specific antibodies
09/16/2008US7425446 host cells into which a gene encoding an antibody is introduced, which is resistant to a section which recognizes a sugar chain in which fucose is bound to N-acetylglucosamine in a complex N-glycoside-linked sugar chain; antibodies used for diseases having antibody-dependent cell-mediated cytotoxicity
09/16/2008US7425424 Combining a labelled test compound with an isolated cell from the spleen, lymph node, thymus or a B-cell lymphocyte comprising a heterlogous polypeptide; determining kinase activity; drug screening, medical diagnosis; genetic engineering
09/16/2008US7425333 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7
09/16/2008US7425330 Methods of inhibiting TNFα activity in the blood of a patient
09/16/2008US7425329 Methods for treating bone cancer pain by administering a nerve growth factor antagonist
09/16/2008US7425328 Comprises immunoglobulin which binds tissue factor and prevents blood coagulation for use as tool in treatment of thrombosis and thromboembolic disorders
09/16/2008US7425327 Choline binding proteins for anti-pneumococcal vaccines
09/16/2008US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies
09/16/2008US7425317 Diagnosis, therapy of tumors, cancer
09/16/2008CA2467801C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs
09/16/2008CA2409748C Soluble ctla4 mutant molecules and uses thereof
09/16/2008CA2376193C Therapeutic agent comprising a botulinum neurotoxin
09/16/2008CA2313609C Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease
09/16/2008CA2292730C Stabilized antibody formulation
09/16/2008CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods
09/16/2008CA2132091C Antibodies to alphavbeta3 integrin
09/16/2008CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
09/16/2008CA2102301C Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
09/12/2008WO2008109742A1 Modulation of complement system activation for treatment of bleeding-related inflammation
09/12/2008WO2008108918A1 Human antibodies against hepatitis c virus (hcv) uses thereof
09/12/2008WO2008108910A2 Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy
09/12/2008WO2008108257A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
09/12/2008WO2008107641A1 Liposome preparation
09/12/2008WO2008107523A2 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins
09/12/2008WO2008107422A1 Osteopontin for the prediction and treatment of cardiovascular diseases
09/12/2008WO2008107260A1 Coupling of antibody polypeptides at the c-terminus
09/12/2008WO2008107187A1 Antibodies specific for rubella virus
09/12/2008WO2008106980A2 Recombinant antibodies for treatment of respiratory syncytial virus infections
09/12/2008WO2008106709A1 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
09/12/2008WO2008106707A1 Method of determining nt-probnp
09/12/2008WO2008080623A3 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo